Oddvar Solli

Author information from the last article

Oddvar Solli er ph.d. i Health Economics, Policy and Management, cand.polit. i samfunnsøkonomi, og leder for helseøkonomene i Pfizer i Norge.

Articles by Oddvar Solli

Introduction of new health technologies – is the patient being heard?

David Mwaura,
Oddvar Solli,
Erik Hjelvin

04.04.2022: Patients and service users are not really involved in the process for assessing new health technologies. Other countries have much better systems in place, and these should be adopted in Norway. The system for assessing which health technologies should be introduced and financed by the Norwegian...

Good reasons for confidential drug prices

Jens Torup Østby,
Oddvar Solli

11.03.2019: The price alone is insufficient to assess whether a new drug is too costly. For many years, manufacturers have been permitted to offer confidential discounts in tenders for pharmaceutical drugs and vaccines in Norway. The establishment of the National System for Managed Introduction of New Health...